| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.4 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.4 |